FLT3L and Plerixafor Combination Increases Hematopoietic Stem Cell Mobilization and Leads to Improved Transplantation Outcome

Hematopoietic stem cell (HSC) transplantation has curative potential for patients with hematological malignancies. Clinically, HSCs derived from mobilized peripheral blood are used more frequently than bone marrow. However, current standard mobilizing agents yield grafts that may not contain suffici...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: He, Shun, Chu, Jianhong, Vasu, Sumithira, Deng, Youcai, Yuan, Shunzong, Zhang, Jianying, Fan, Zhijin, Hofmeister, Craig C., He, Xiaoming, Marsh, Henry C., Devine, Steven M., Yu, Jianhua
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3943635/
https://ncbi.nlm.nih.gov/pubmed/24365795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.11.024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars